These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P, Kant KS, Allen C, Pollak VE. J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000 [Abstract] [Full Text] [Related]
3. Human articular cartilage contains an inhibitor of plasminogen activator. Yamada H, Stephens RW, Nakagawa T, McNicol D. J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880 [Abstract] [Full Text] [Related]
4. Separation of plasminogen activators from human uterine tissue and a comparison with activators from human urine and porcine tissue. Kok P. Thromb Haemost; 1979 Jun 30; 41(4):718-33. PubMed ID: 113901 [Abstract] [Full Text] [Related]
5. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator. Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D. Thromb Haemost; 1988 Oct 31; 60(2):247-50. PubMed ID: 3146141 [Abstract] [Full Text] [Related]
8. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions. Hamaguchi Y, Ohi M, Sakakura Y, Miyoshi Y. Ann Otol Rhinol Laryngol; 1985 Oct 31; 94(3):293-6. PubMed ID: 3925865 [Abstract] [Full Text] [Related]
9. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O, Rijken DC, Collen D. Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339 [Abstract] [Full Text] [Related]
10. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Gross JL, Behrens DL, Mullins DE, Kornblith PL, Dexter DL. Cancer Res; 1988 Jan 15; 48(2):291-6. PubMed ID: 3121170 [Abstract] [Full Text] [Related]
12. Plasminogen activators and urokinase inhibitors in the lungs of foetuses and newborns. Uszynska-Folejewska R. Anaesth Resusc Intensive Ther; 1976 Jan 15; 4(1):41-5. PubMed ID: 970616 [Abstract] [Full Text] [Related]
13. The inhibition of tissue activator and urokinase by human plasma. Walker JE, Ogston D. Thromb Haemost; 1982 Jun 28; 47(3):265-8. PubMed ID: 6180497 [Abstract] [Full Text] [Related]
14. Immunological characterization of plasminogen activator activities in human tissues and body fluids. Rijken DC, Wijngaards G, Welbergen J. J Lab Clin Med; 1981 Apr 28; 97(4):477-86. PubMed ID: 6782183 [Abstract] [Full Text] [Related]
15. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)]. Félez J, Rueda F. Sangre (Barc); 1985 Apr 28; 30(4-C):779-86. PubMed ID: 3937250 [No Abstract] [Full Text] [Related]
17. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Astedt B, Lecander I, Brodin T, Lundblad A, Löw K. Thromb Haemost; 1985 Feb 18; 53(1):122-5. PubMed ID: 3922076 [Abstract] [Full Text] [Related]
18. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N. Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727 [Abstract] [Full Text] [Related]
19. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH, Diamond SL. Thromb Haemost; 1995 Aug 03; 74(2):711-7. PubMed ID: 8585011 [Abstract] [Full Text] [Related]
20. Plasminogen activators and inhibitors are transcribed during early macaque implantation. Feng Q, Liu K, Liu YX, Byrne S, Ockleford CD. Placenta; 2001 Aug 03; 22(2-3):186-99. PubMed ID: 11170823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]